CFG
ALXN

Citizens Financial Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Citizens Financial Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-176
Closed -$16K – 1235
2020
Q1 		$16K Sell
176
-26
-13% -$2.55K ﹤0.01% 655
2019
Q4 		$22K Sell
202
-105
-34% -$11.2K ﹤0.01% 605
2019
Q3 		$30K Sell
307
-1
-0.3% -$113 ﹤0.01% 422
2019
Q2 		$41K Buy
308
+48
+18% +$6.19K ﹤0.01% 385
2019
Q1 		$35K Buy
260
+60
+30% +$7.46K ﹤0.01% 393
2018
Q4 		$19K Buy
+200
New +$23.6K ﹤0.01% 362
2016
Q3 		– Sell
-361
Closed -$42K – 715
2016
Q2 		$42K Hold
361
– – ﹤0.01% 376
2016
Q1 		$50K Sell
361
-65
-15% -$9.54K ﹤0.01% 364
2015
Q4 		$81K Buy
+426
New +$74.4K 0.01% 328

Other funds holding ALXN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citizens Financial Group's ALXN Position: Q2 2020 in Review

Citizens Financial Group sold out of Alexion Pharmaceuticals (ALXN) in Q2 2020, closing a stake of 176 shares — an estimated $16K sold.

Citizens Financial Group first reported a position in ALXN in Q4 2015 and held it in 9 quarters. The position peaked at $81K in Q4 2015. 707 funds tracked by Wall St. Rank hold ALXN as of Q2 2020.

  • Citizens Financial Group reported no remaining Alexion Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Citizens Financial Group sold 176 Alexion Pharmaceuticals shares in Q2 2020, an estimated $16K.
  • Citizens Financial Group first reported a position in Alexion Pharmaceuticals in Q4 2015 and held it in 9 quarters.
  • Citizens Financial Group's Alexion Pharmaceuticals position peaked at $81K in Q4 2015.
  • 707 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2020.

Based on Citizens Financial Group's 13F filing for Q2 2020, filed 12 Aug 2020.